Clinical Trials Directory

Trials / Completed

CompletedNCT05423340

Effect of E-Liquid Flavor on Respiratory Symptoms in People Using Electronic Nicotine Delivery Systems

A Randomized, Parallel-group Open-label Trial of ENDS Users Switching From Flavors of Potentially High-toxicity Profile to Flavors of Potentially Low-toxicity Profile (CRoFT_3.2)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
163 (actual)
Sponsor
Roswell Park Cancer Institute · Academic / Other
Sex
All
Age
21 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a randomized, parallel-group open-label trial to evaluate respiratory symptoms in ENDS users switching from banned flavors to a non-banned flavor (tobacco) or 'tobacco free' nicotine pouches.

Conditions

Interventions

TypeNameDescription
OTHERE-cigarette FlavorParticipants use an electronic nicotine delivery system with an assigned tobacco-flavored e-liquid
OTHERTobacco Free Nicotine Pouchparticipants will use tobacco free oral nicotine pouches

Timeline

Start date
2022-06-12
Primary completion
2024-10-03
Completion
2024-10-03
First posted
2022-06-21
Last updated
2025-01-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05423340. Inclusion in this directory is not an endorsement.